| Title: | Amgen at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript |
| Price: | $54.00 |
| Publication Date: | May 01, 2008 |
| Source: | Thomson StreetEvents |
| Report Type: | Transcript |
| Abstract: | Final Transcript of AMGN presentation, 1-May-08 10:00am ET |
| Brief Excerpt: | ... - Morgan Stanley - AnalystThanks, everybody. Next we have Amgen. We have Bob Bradway, the CFO, and Arvind Sood, who is the Director of Investor Relations. For those of you who are listening on the webcast, you can go to www.MorganStanley.com for our disclosures. For those of you here, they are out in the hallway as we talked about before, I'm sure you have yours on the website as well because we are optimistic you will make some forward-looking statements. I will start with a general question to begin with. It has been a very difficult operational year for Amgen. With the safety issues that you have dealt with on the erythropoietin business, the necessity to change the size of your business, just give a little bit of an overview of where you are in restructuring this business to one, find areas where you can drive topline growth, and two, getting the right operational infrastructure in place to ensure that you can protect your bottom line while still looking for long-term growth as well?... |
| Word Count: | 8421 |
| Length: | 15 Pages |
| Ticker: | AMGN |
| Time: | 10:00am ET |
| Related Report(s): | |
| Format: | 
Adobe Acrobat
|
| Free Sample: |
Click
Here
to Download
|
Looking For Something Else?
